Literature DB >> 2410354

Activation and proliferation signals in mouse B cells. VI. Anti-Ig antibodies induce dose-dependent cell cycle progression in B cells.

G G Klaus, C M Hawrylowicz, C J Carter.   

Abstract

Recent studies from several laboratories have shown that the concentrations of anti-immunoglobulin antibodies required to induce B lymphocytes to synthesize DNA are quite different from those needed to activate these cells, i.e. to cause resting B cells to leave G0. The present experiments examine this difference in detail. Thus, stimulation of DNA synthesis in mouse B cells requires prolonged (greater than 30 hr) exposures to high (greater than or equal to 10 micrograms/ml) concentrations of soluble F(ab')2 fragments of rabbit anti-Ig antibodies. However, as little as 50 ng/ml antibody caused B cells to enlarge, to express increased levels of Ia antigens, and to become primed to synthesize DNA more rapidly in response to restimulation with mitogenic concentrations of anti-Ig. The results of kinetic experiments suggested that the 'distance' that cells progress from G0 towards S depends not only on the time of exposure to anti-Ig, but also on its concentration. Concentrations of antibody less than 1 microgram/ml did not induce detectable RNA synthesis, and hence do not drive cells into the G1 phase of the cell cycle. Instead, under these conditions, B cells appear to enter a transitional, primed state (which has been termed GIT). This may well reflect the state into which T-dependent antigens drive resting B cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2410354      PMCID: PMC1453634     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  Lymphocyte stimulation: a rapid multiparameter analysis.

Authors:  Z Darzynkiewicz; F Traganos; T Sharpless; M R Melamed
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

2.  Sorting of B lymphoblasts based upon cell diameter provides cell populations enriched in different stages of cell cycle.

Authors:  J G Monroe; J C Cambier
Journal:  J Immunol Methods       Date:  1983-09-30       Impact factor: 2.303

3.  Increased expression of I-region-associated antigen (Ia) on B cells after cross-linking of surface immunoglobulin.

Authors:  J J Mond; E Seghal; J Kung; F D Finkelman
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

4.  Human T lymphocyte/monocyte interaction in response to lectin: kinetics of entry into the S-phase.

Authors:  A L Maizel; S R Mehta; S Hauft; D Franzini; L B Lachman; R J Ford
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

5.  Level of mIa expression on mitogen-stimulated murine B lymphocytes is dependent on position in cell cycle.

Authors:  J G Monroe; J C Cambier
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

6.  B cell activation. IV. Induction of cell membrane depolarization and hyper-I-A expression by phorbol diesters suggests a role for protein kinase C in murine B lymphocyte activation.

Authors:  J G Monroe; J E Niedel; J C Cambier
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

7.  Activation of mouse lymphocytes by anti-immunoglobulin. I. Parameters of the proliferative response.

Authors:  D G Sieckmann; R Asofsky; D E Mosier; I M Zitron; W E Paul
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

Review 8.  Regulation of growth and proliferation in B cell subpopulations.

Authors:  A L DeFranco; J T Kung; W E Paul
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

9.  Frequency of B lymphocytes responsive to anti-immunoglobulin.

Authors:  A L Defranco; E S Raveche; R Asofsky; W E Paul
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

10.  B cell activation. III. B cell plasma membrane depolarization and hyper-Ia antigen expression induced by receptor immunoglobulin cross-linking are coupled.

Authors:  J G Monroe; J C Cambier
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Membrane Ig-mediated triggering of B cell tolerance and B cell clonal expansion: implications for rheumatoid factor production in rheumatoid synovitis.

Authors:  P K Mongini; S M Rudich
Journal:  Springer Semin Immunopathol       Date:  1989

2.  Tolerogenicity of resting and activated B cells.

Authors:  K M Gilbert; W O Weigle
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

3.  B-cell-stimulatory factor 1 reverses Fc receptor-mediated inhibition of B-lymphocyte activation.

Authors:  A O'Garra; K P Rigley; M Holman; J B McLaughlin; G G Klaus
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

4.  Interleukin 4 (B-cell growth factor II/eosinophil differentiation factor) is a mitogen and differentiation factor for preactivated murine B lymphocytes.

Authors:  A O'Garra; D J Warren; M Holman; A M Popham; C J Sanderson; G G Klaus
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

5.  B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells.

Authors:  R J Grumont; I J Rourke; L A O'Reilly; A Strasser; K Miyake; W Sha; S Gerondakis
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

6.  Anti-IgM-mediated B cell signaling. Molecular analysis of ligand binding requisites for human B cell clonal expansion and tolerance.

Authors:  S M Rudich; K H Roux; R J Winchester; P K Mongini
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

7.  Crosslinking of surface immunoglobulin and Fc receptors on B lymphocytes inhibits stimulation of inositol phospholipid breakdown via the antigen receptors.

Authors:  M K Bijsterbosch; G G Klaus
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.